Literature DB >> 27511849

Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.

Brian C Baumann1, Walter R Bosch2, Amit Bahl3, Alison J Birtle4, Rodney H Breau5, Amarnath Challapalli3, Albert J Chang6, Ananya Choudhury7, Sia Daneshmand8, Ali El-Gayed9, Adam Feldman10, Steven E Finkelstein11, Thomas J Guzzo1, Serena Hilman3, Ashesh Jani12, S Bruce Malkowicz1, Constantine A Mantz13, Viraj Master12, Anita V Mitra14, Vedang Murthy15, Sima P Porten6, Pierre M Richaud16, Paul Sargos16, Jason A Efstathiou10, Libni J Eapen5, John P Christodouleas17.   

Abstract

PURPOSE: To develop multi-institutional consensus clinical target volumes (CTVs) and organs at risk (OARs) for male and female bladder cancer patients undergoing adjuvant radiation therapy (RT) in clinical trials. METHODS AND MATERIALS: We convened a multidisciplinary group of bladder cancer specialists from 15 centers and 5 countries. Six radiation oncologists and 7 urologists participated in the development of the initial contours. The group proposed initial language for the CTVs and OARs, and each radiation oncologist contoured them on computed tomography scans of a male and female cystectomy patient with input from ≥1 urologist. On the basis of the initial contouring, the group updated its CTV and OAR descriptions. The cystectomy bed, the area of greatest controversy, was contoured by another 6 radiation oncologists, and the cystectomy bed contouring language was again updated. To determine whether the revised language produced consistent contours, CTVs and OARs were redrawn by 6 additional radiation oncologists. We evaluated their contours for level of agreement using the Landis-Koch interpretation of the κ statistic.
RESULTS: The group proposed that patients at elevated risk for local-regional failure with negative margins should be treated to the pelvic nodes alone (internal/external iliac, distal common iliac, obturator, and presacral), whereas patients with positive margins should be treated to the pelvic nodes and cystectomy bed. Proposed OARs included the rectum, bowel space, bone marrow, and urinary diversion. Consensus language describing the CTVs and OARs was developed and externally validated. The revised instructions were found to produce consistent contours.
CONCLUSIONS: Consensus descriptions of CTVs and OARs were successfully developed and can be used in clinical trials of adjuvant radiation therapy for bladder cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27511849      PMCID: PMC5207044          DOI: 10.1016/j.ijrobp.2016.04.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation.

Authors:  Simon K Warfield; Kelly H Zou; William M Wells
Journal:  IEEE Trans Med Imaging       Date:  2004-07       Impact factor: 10.048

2.  External validation of a model to predict locoregional failure after radical cystectomy.

Authors:  Michael Froehner; Vladimir Novotny; Manfred P Wirth; Sabine Brookman-May; Atiqullah Aziz; Matthias May
Journal:  Cancer       Date:  2014-07-12       Impact factor: 6.860

3.  Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients.

Authors:  Ja Hyeon Ku; Myong Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

Review 4.  Adjuvant Radiation for Locally Advanced Bladder Cancer? A Question Worth Asking.

Authors:  John P Christodouleas; Wei-Ting Hwang; Brian C Baumann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-19       Impact factor: 7.038

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.

Authors:  John P Christodouleas; Brian C Baumann; Jiwei He; Wei-Ting Hwang; Kai N Tucker; Justin E Bekelman; Catherine M Tangen; Seth P Lerner; Thomas J Guzzo; S Bruce Malkowicz; Harry Herr
Journal:  Cancer       Date:  2014-01-03       Impact factor: 6.860

7.  Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control.

Authors:  M S Zaghloul; H K Awwad; H H Akoush; S Omar; O Soliman; I el Attar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

8.  Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.

Authors:  Brian C Baumann; Thomas J Guzzo; Jiwei He; David J Vaughn; Stephen M Keefe; Neha Vapiwala; Curtiland Deville; Justin E Bekelman; Kai Tucker; Wei-Ting Hwang; S Bruce Malkowicz; John P Christodouleas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-30       Impact factor: 7.038

9.  Adjuvant radiation therapy for bladder cancer: a dosimetric comparison of techniques.

Authors:  Brian C Baumann; Kate Noa; E Paul Wileyto; Justin E Bekelman; Curtiland Deville; Neha Vapiwala; Maura Kirk; Stefan Both; Derek Dolney; Ali Kassaee; John P Christodouleas
Journal:  Med Dosim       Date:  2015-08-29       Impact factor: 1.482

10.  RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.

Authors:  Colleen A F Lawton; Jeff Michalski; Issam El-Naqa; Mark K Buyyounouski; W Robert Lee; Cynthia Menard; Elizabeth O'Meara; Seth A Rosenthal; Mark Ritter; Michael Seider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-22       Impact factor: 7.038

View more
  14 in total

1.  Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.

Authors:  Mohamed S Zaghloul; John P Christodouleas; Andrew Smith; Ahmed Abdallah; Hany William; Hussein M Khaled; Wei-Ting Hwang; Brian C Baumann
Journal:  JAMA Surg       Date:  2018-01-17       Impact factor: 14.766

Review 2.  Trimodality therapy for bladder cancer: modern management and future directions.

Authors:  Anthony Pham; Leslie K Ballas
Journal:  Curr Opin Urol       Date:  2019-05       Impact factor: 2.309

Review 3.  Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Authors:  Kristen Mcalpine; Dean A Fergusson; Rodney H Breau; Luke F Reynolds; Risa Shorr; Scott C Morgan; Libni Eapen; Ilias Cagiannos; Chris Morash; Luke T Lavallée
Journal:  Can Urol Assoc J       Date:  2018-05-28       Impact factor: 1.862

4.  National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.

Authors:  Zhoobin H Bateni; Shane M Pearce; Daniel Zainfeld; Leslie Ballas; Hooman Djaladat; Anne K Schuckman; Siamak Daneshmand
Journal:  Eur Urol Oncol       Date:  2018-12-19

5.  Leiomyosarcoma of urinary bladder with unusual recurrence in intestinal mucosa and peritoneum: a case report.

Authors:  Poorva Vias; Shikha Goyal; Kannan Periasamy; Renu Madan; Sudheer Kumar Devana; Amanjit Bal; Reetu Kundu
Journal:  J Egypt Natl Canc Inst       Date:  2021-12-13

6.  GUROPA survey: genito-urinary radiation oncology prescription attitudes.

Authors:  Sergio Fersino; Stefano Arcangeli; Barbara Alicja Jereczek-Fossa; Rolando D'Angelillo; Filippi Bertoni; Giuseppe Roberto D'Agostino; Luca Triggiani; Renzo Corvò; Stefano Maria Magrini; Filippo Alongi
Journal:  Radiol Med       Date:  2018-07-13       Impact factor: 3.469

7.  The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer.

Authors:  Gary D Lewis; Waqar Haque; Vivek Verma; E Brian Butler; Bin S Teh
Journal:  Bladder Cancer       Date:  2018-04-26

8.  Intensity-Modulated Radiotherapy is Superior to Three-Dimensional Conformal Radiotherapy in the Trimodality Management of Muscle-Invasive Bladder Cancer with Daily Cone Beam Computed Tomography Optimization.

Authors:  Alexander D Sherry; Adam Stewart; Guozhen Luo; Austin N Kirschner
Journal:  J Radiat Oncol       Date:  2019-12-18

Review 9.  The Rationale for Post-Operative Radiation in Localized Bladder Cancer.

Authors:  Brian C Baumann; Paul Sargos; Libni J Eapen; Jason A Efstathiou; Ananya Choudhury; Amit Bahl; Vedang Murthy; Leslie K Ballas; Valérie Fonteyne; Pierre M Richaud; Mohamed S Zaghloul; John P Christodouleas
Journal:  Bladder Cancer       Date:  2017-01-27

10.  Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?

Authors:  Kevin Lm Chua; Grace Kusumawidjaja; Jure Murgic; Melvin Lk Chua
Journal:  ESMO Open       Date:  2017-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.